# Dilp8 requires the neuronal relaxin receptor Lgr3 to couple growth to developmental timing

**Authors:** Andres Garelli, Fabiana Heredia, Andreia P. Casimiro, Andre Macedo, Catarina Nunes, Marcia Garcez, Angela R. Mantas Dias, Yanel A. Volonte, Thomas Uhlmann, Esther Caparros, Takashi Koyama, Alisson M. Gontijo

PMC · DOI: 10.1038/ncomms9732 · 2015-10-29

## TL;DR

This study identifies a new role for the Lgr3 receptor in Drosophila, linking organ growth to developmental timing through a neuroendocrine pathway involving Dilp8.

## Contribution

The paper reveals that Lgr3 is a functional relaxin receptor required for Dilp8 signaling in coordinating growth and developmental timing.

## Key findings

- Mutating Lgr3 causes body asymmetries similar to dilp8 mutants, indicating a shared pathway.
- Lgr3 activity is localized to specific CNS neurons that respond to Dilp8 by increasing cAMP signaling.
- Lgr3 is essential for the developmental delay caused by growth perturbations or Dilp8 overexpression.

## Abstract

How different organs in the body sense growth perturbations in distant tissues to coordinate their size during development is poorly understood. Here we mutate an invertebrate orphan relaxin receptor gene, the Drosophila Leucine-rich repeat-containing G protein-coupled receptor 3 (Lgr3), and find body asymmetries similar to those found in insulin-like peptide 8 (dilp8) mutants, which fail to coordinate growth with developmental timing. Indeed, mutation or RNA intereference (RNAi) against Lgr3 suppresses the delay in pupariation induced by imaginal disc growth perturbation or ectopic Dilp8 expression. By tagging endogenous Lgr3 and performing cell type-specific RNAi, we map this Lgr3 activity to a new subset of CNS neurons, four of which are a pair of bilateral pars intercerebralis Lgr3-positive (PIL) neurons that respond specifically to ectopic Dilp8 by increasing cAMP-dependent signalling. Our work sheds new light on the function and evolution of relaxin receptors and reveals a novel neuroendocrine circuit responsive to growth aberrations.

The orphan ligand Dilp8 has been shown to coordinate growth and developmental timing in Drosophila. Here, using Gal4 drivers and CRISPR/Cas9 approaches, Garelli et al. identify a role for relaxin-like receptor Lgr3 in regulating the Dilp8 developmental delay pathway.

## Linked entities

- **Genes:** TSHR (thyroid stimulating hormone receptor) [NCBI Gene 7253], Ilp8 (Insulin-like peptide 8) [NCBI Gene 39909]
- **Proteins:** Ilp8 (Insulin-like peptide 8)
- **Species:** Drosophila (taxon 7215)

## Full-text entities

- **Genes:** Lgr4 (Leucine-rich repeat-containing G protein-coupled receptor 4) [NCBI Gene 5740505] {aka CG32637, CG34411, CG4187, DLGR4, Dmel\CG34411, Dmel_CG32637}, Wnt5 (Wnt oncogene analog 5) [NCBI Gene 32838] {aka CG6407, DWnt-3, DWnt-3/5, DWnt-5, DWnt3, DWnt3/5}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, PDF (peptide deformylase, mitochondrial) [NCBI Gene 64146], Ilp8 (Insulin-like peptide 8) [NCBI Gene 39909] {aka CG14059, DILP 8, DILP1 8, DILP8, DILPs, Dilp8}, elav (embryonic lethal abnormal vision) [NCBI Gene 31000] {aka 44C11, 9F8A9, CG4262, Dmel\CG4262, EC7, EG:65F1.2}, Bx (Beadex) [NCBI Gene 32846] {aka Bd, CG10548, CG15048, CG44425, CG6500, DLMO}, TSHR (thyroid stimulating hormone receptor) [NCBI Gene 7253] {aka CHNG1, LGR3, hTSHR-I}, drl (derailed) [NCBI Gene 44355] {aka CG10758, CG17348, Dmel\CG17348, lin, lio, lio/drl}, LRR (Leucine-rich repeat) [NCBI Gene 35715] {aka CG1399, CG1576, Carmil, Dmel\CG1399, Dmel\LRR}, rpr (reaper) [NCBI Gene 40015] {aka CG4319, Dmel\CG4319, Reaper, anon-WO0162936.19, rp}, Nrg (Neuroglian) [NCBI Gene 31792] {aka CG1634, CT4318, Dmel\CG1634, NFASC, Ngl, Nrg167}, betaTub85D (beta-Tubulin at 85D) [NCBI Gene 41124] {aka 2t, B2t, BETA 85D, BETA2, CG9359, D.m.BETA-85D}, Lgr3 (Leucine-rich repeat-containing G protein-coupled receptor 3) [NCBI Gene 43098] {aka CG31096, CG5042, CG5046, CT16193, DLGR3, Dmel\CG31096}, tub (tube) [NCBI Gene 40554] {aka CG10520, Dmel\CG10520, TUBE, Tube}, ball (ballchen) [NCBI Gene 43228] {aka BcDNA:LD09009, CG6386, Dmel\CG6386, NHK-1, NHK1, VRK}, RpL32 (Ribosomal protein L32) [NCBI Gene 43573] {aka 143250_at, BcDNA:RH03940, CG7939, Dmel\CG7939, L32, L32e}, LGALS4 (galectin 4) [NCBI Gene 3960] {aka GAL4, L36LBP}, Ptth (Prothoracicotropic hormone) [NCBI Gene 33238] {aka CG13687, Dmel\CG13687}, Sur (Sulfonylurea receptor) [NCBI Gene 34350] {aka BEST:CK00325, CG5772, CK00325, DSur, DmSUR, Dme_CG5772}, mil (milkah) [NCBI Gene 43343] {aka CG5017, Dmel\CG5017, hanabi, tNAP}, Thor (thor) [NCBI Gene 33569] {aka 153432_at, 43-BP, 4E-BP, 4E-BP1, 4EBP, 4e-BP}, foxo (forkhead box, sub-group O) [NCBI Gene 41709] {aka 3143, Afx, Akh, CG3143, DFOXO, DfoxO}, Sil1 (SIL1 nucleotide exchange factor) [NCBI Gene 291673], Ilp1 (Insulin-like peptide 1) [NCBI Gene 39149] {aka CG14173, DILP, DILP 1, DILP-1, DILP1, DILPs}, Gad1 (Glutamic acid decarboxylase 1) [NCBI Gene 38484] {aka CG14994, DGAD1, DGad1, Dm-GDC, Dmel\CG14994, GAD}, VGlut (Vesicular glutamate transporter) [NCBI Gene 33427] {aka CG9887, DV-Glut, DVGLUT, DVGluT, DVGlut, Dmel\CG9887}, InR (Insulin-like receptor) [NCBI Gene 42549] {aka 18402, CG18402, DIHR, DILR, DIR, DIRH}, ChAT (Choline acetyltransferase) [NCBI Gene 42249] {aka CG12345, CLAT_DROME, CT23399, Cat, ChA, ChAT4B1}, Ilp7 (Insulin-like peptide 7) [NCBI Gene 31328] {aka CG13317, DILP, DILP 7, DILP-7, DILP7, DILPs}, Sil1 (Sil1 nucleotide exchange factor) [NCBI Gene 43034] {aka CG10420, Dmel\CG10420}, Ilp5 (Insulin-like peptide 5) [NCBI Gene 2768992] {aka CG33273, DILP, DILP 5, DILP-5, DILP5, DILPs}, Ctl2 (Choline transporter-like 2) [NCBI Gene 43440] {aka CG11880, CTLH2, DmCTL2, Dmel\CG11880}, scb (scab) [NCBI Gene 36692] {aka &agr-PS3, CG8095, CT21280, CT36929, Dm0620, Dmel\CG8095}, so (sine oculis) [NCBI Gene 35662] {aka CG11121, Dmel\CG11121, Drl, Sine oculis, ami, mda}
- **Diseases:** PTC (OMIM:300244), developmental delay (MESH:D002658), inflammatory disease (MESH:D007249), PIL (MESH:C537150), growth abnormalities (MESH:D006130), FA (MESH:C565561), cholinergic (MESH:C535672)
- **Chemicals:** agar (MESH:D000362), DAPI (MESH:C007293), glycerol (MESH:D005990), glycopeptides (MESH:D006020), cAMP (MESH:D000242), biotin (MESH:D001710), paraformaldehyde (MESH:C003043), peptides (MESH:D010455), EDTA (MESH:D004492), glycine (MESH:D005998), EMS (MESH:D005020), sucrose (MESH:D013395), FA (MESH:D005492), ethanol (MESH:D000431), ecdysone (MESH:D004440), Act5C (-), NaCl (MESH:D012965), PBS (MESH:D007854),  (MESH:D036341),  (MESH:D012065),  (MESH:C572149)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Drosophila melanogaster (fruit fly, species) [taxon 7227], Diptera (flies, order) [taxon 7147]
- **Cell lines:** PIL — Homo sapiens (Human), Transformed cell line (CVCL_B3I9), CRE-F-luc — Homo sapiens (Human), Ampulla of Vater adenocarcinoma, Cancer cell line (CVCL_EI94), -2A — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_A628), DL2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), SL2 — Homo sapiens (Human), Lung small cell carcinoma, Cancer cell line (CVCL_7010)

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4640092/full.md

---
Source: https://tomesphere.com/paper/PMC4640092